Duplicate Document
This document appears to be a copy. The original version is:
Cowen Cannabis Valuation Methodology Highlights Federal Legal RisksCase Filekaggle-ho-024916House OversightCowen Cannabis Valuation Methodology Highlights Federal Legal Risks
Unknown1p1 persons
Cowen Cannabis Valuation Methodology Highlights Federal Legal Risks
Cowen Cannabis Valuation Methodology Highlights Federal Legal Risks The passage is a standard investment research note describing valuation methods and regulatory risks for cannabis companies. It contains no specific allegations, names, transactions, or actionable leads involving high‑profile actors, making it low‑value for investigative work. Key insights: Uses EV‑to‑Sales multiples for cannabis company valuation.; Notes that cannabis remains illegal under federal law (CSA).; Mentions potential criminal prosecution risk for U.S. cannabis firms.
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.